PURE BIOSCIENCE, INC

PURE
Delayed Quote. Delayed  - 07/23 01:33:12 pm
0.4345USD -0.11%
Valuation
Fiscal Period: July 2019 2020
Capitalization1 24,6124
Entreprise Value (EV)1 24,2120
P/E ratio -3,61x30 426x
Yield --
Capitalization / Revenue 12,9x18,0x
EV / Revenue 12,7x17,4x
EV / EBITDA -4,52x614x
Price to Book 21,0x25,9x
Nbr of stocks (in thousands) 75 58286 891
Reference price (USD) 0,331,43
Announcement Date 10/08/202010/08/2020
Previous period Next period
1 USD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: July 2019 2020
Net sales1 1,916,92
EBITDA1 -5,350,20
Operating profit (EBIT)1 -5,590,00
Operating Margin -293%0,06%
Pre-Tax Profit (EBT)1 -6,550,00
Net income1 -6,550,00
Net margin -343%0,06%
EPS2 -0,090,00
Dividend per Share --
Announcement Date 10/08/202010/08/2020
Previous period Next period
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: July 2019 2020
Net Debt1 --
Net Cash position1 0,403,84
Leverage (Debt / EBITDA) 0,07x-19,6x
Free Cash Flow1 -0,860,61
ROE (Net Profit / Equities) -530%0,13%
Shareholders' equity1 1,243,00
ROA (Net Profit / Asset) -155%0,06%
Assets1 4,236,61
Book Value Per Share2 0,020,06
Cash Flow per Share2 0,010,04
Capex1 0,010,06
Capex / Sales 0,37%0,84%
Announcement Date 10/08/202010/08/2020
Previous period Next period
1 USD in Million
2 USD
EPS & Dividend